The elusive crystal structure of the neuraminidase inhibitor Tamiflu (oseltamivir phosphate): Molecular details of action

Pance Naumov, Nobuhiro Yasuda, Wael M. Rabeh, Joel Bernsteina

Research output: Contribution to journalArticle

Abstract

The first structure determination of a neuraminidase inhibitor, oseltamivir phosphate, the active component of the anti-influenza agent Tamiflu, was achieved by single crystal X-ray diffraction with synchrotron radiation. The structure reproduces to a great extent the binding of the inhibitor in the neuraminidase active site and provides more accurate structural parameters as well as detailed insight into the binding preferences of the inhibitor.

Original languageEnglish (US)
Pages (from-to)1948-1950
Number of pages3
JournalChemical Communications
Volume49
Issue number19
DOIs
StatePublished - Feb 7 2013

ASJC Scopus subject areas

  • Catalysis
  • Electronic, Optical and Magnetic Materials
  • Ceramics and Composites
  • Chemistry(all)
  • Surfaces, Coatings and Films
  • Metals and Alloys
  • Materials Chemistry

Fingerprint Dive into the research topics of 'The elusive crystal structure of the neuraminidase inhibitor Tamiflu (oseltamivir phosphate): Molecular details of action'. Together they form a unique fingerprint.

Cite this